微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.34% | 27.97% | 13.22% | 24/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.95% | 62.09% | 2.43% | 14/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 2.88% | 188% | 82.28% | 6/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 1.58% | 128.42% | -39.46% | 33/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 2.61% | 63.13% | 43.41% | 37/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 1.82% | 26.39% | 82% | 31/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1% | 400% | 117.99% | 33/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -5.56% | -505.84% | -447.5% | 40/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 1.6% | -81.15% | 11.11% | 37/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 1.44% | 620% | 620% | 35/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 0.2% | 17.65% | -85.4% | 34/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 1.37% | 102.85% | -83.86% | 37/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 8.49% | 286.18% | 4145% | 23/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 0.2% | 107.02% | 17.65% | 37/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.17% | 13.33% | 100.35% | 25/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -48.01% | -6255.13% | -952.85% | 49/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -4.56% | -185.88% | -60% | 29/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -2.85% | -187.16% | -2000% | 33/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 0.15% | -94.76% | -80.77% | 19/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 0.78% | 101.32% | -85.31% | 38/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 5.31% | 39.01% | 62.39% | 18/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 3.27% | 11.6% | 14.34% | 18/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 2.86% | 57.14% | 104.83% | 8/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -59.17% | -107.91% | -1648.95% | 46/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 3.82% | 32.18% | 30.38% | 18/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 2.93% | 56.68% | 60.99% | 16/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.82% | 111.63% | 106.39% | 11/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | -28.46% | -31.52% | -1084.78% | 40/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 2.89% | 111.5% | 54.55% | 22/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 1.87% | 103.28% | 117.44% | 22/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 0.86% | 103.97% | 103.97% | 17/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | -21.64% | 74.95% | 13.92% | 32/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | -25.14% | 8.45% | 55.86% | 21/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | -56.96% | -217.33% | -162.97% | 24/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | -21.66% | -191.52% | 74.92% | 20/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | -86.37% | -198.96% | -214.53% | 30/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | -27.46% | -77.62% | -52.98% | 21/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | -17.95% | -219.4% | -141.59% | 20/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | -7.43% | -628.43% | 74.28% | 19/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |